Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Cure SMA image

News from Cure SMA

Stay current with all the latest and breaking news from Cure SMA. Compare headlines and media bias behind news outlets on stories breaking today.

In total, 4 have been published by Cure SMA which Ground News has aggregated in the past 3 months.

Ground News rates Cure SMA’s media bias as unknown. . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Cure SMA’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Cure SMA

Where is Cure SMA located?Cure SMA's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Cure SMA News

Cure SMA Celebrates Dr. Mary Schroth as she Retires as Chief Medical Officer

United States · United States

Cure SMA Celebrates Dr. Mary Schroth as she Retires as Chief Medical Officer

We are honored to celebrate the incredible contributions of Dr. Mary Schroth, who is retiring after seven years as our Chief Medical Officer and after many decades of service and care for our community. Honoring Dr. Mary Schroth’s Legacy For several decades, Dr. Mary Schroth has been a driving force in advancing clinical care for individuals with SMA. Her dedication has transformed Cure SMA’s clinical care programs, significantly improving t…Read Article

FDA Grants Priority Review BLA for Spinal Muscular Atrophy Drug, Apitegromab

A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.FDA · United States See the Story

You've scrolled to the bottom of the feed, there are no more stories.

Our use of cookiesCookie policy

Unlike other news sites, we do not share or sell your data to third-parties for targeted ads. In fact, the Ground News application and website do not run any ads at all. Our application and website use cookies and similar technologies to personalize content we deliver to you and also allows us to improve your usage of our platform through analytics. These cookies help us provide the best experience possible. Learn more about cookies and preference selection here.

By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.